{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:12:41Z","timestamp":1778260361944,"version":"3.51.4"},"reference-count":26,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,3,14]]},"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>High blood pressure (BP) affects over 40% of adults over the age of 25 worldwide and is the leading global risk factor for death or disability. Hypertension is also the most important risk factor for endovascular atherosclerosis, which, when combined with other cardiovascular risk factors, leads to atherosclerotic cardiovascular disease (ASCVD). Statins are one of the most widely used drugs for the prevention of ASCVD. The recently announced study of Heart Outcomes Prevention Evaluation-3 suggests that cholesterol-lowering agents combined with antihypertensive therapy can prevent cardiovascular events and reduce the combined endpoint. We plan to conduct a systematic review and meta-analysis to evaluate whether combined antihypertensive and statin therapy is more beneficial than antihypertensive therapy alone in patients with hypertension without complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will perform a comprehensive search for randomised controlled trials evaluating combined antihypertensive and statin therapy for the treatment of patients with hypertension. The following English electronic databases will be searched: The Cochrane Library, EMBASE and PubMed. Outcomes will be categorised as short-term (\u22646 months) or long-term (&gt;6 months). When evaluating the effects of combined antihypertensive and statin therapy, a short-term outcome is usually defined as a change in BP or lipid levels, while a long-term outcome is usually defined as cardiovascular benefits or risks. The data screening and extraction will be conducted by two different reviewers. The quality of the RCTs will be assessed according to the Cochrane handbook risk of bias tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This review does not require ethics approval and the results of the meta-analysis will be submitted to a peer-review journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>\n                      CRD\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?ID=42017071935\" ext-link-type=\"uri\">42017071935<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-019719","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:30Z","timestamp":1527811230000},"page":"e019719","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Combined antihypertensive and statin therapy for the prevention of cardiovascular events in patients with hypertension without complications: protocol for a systematic review and meta-analysis"],"prefix":"10.1136","volume":"8","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First People\u2019s Hospital of Chenzhou, University of South China, Chenzhou, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Min","family":"Kuang","sequence":"additional","affiliation":[{"name":"Department of Hypertension, Beijing Anzhen Hospital of Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Jun","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First People\u2019s Hospital of Chenzhou, University of South China, Chenzhou, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Cardiovascular Disease, The Second Affiliated Hospital of Nanchang University, Nanchang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Xian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medical Affairs, Hisun Pfizer Pharmaceuticals Co., Ltd, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yun","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Medical Affairs, Hisun Pfizer Pharmaceuticals Co., Ltd, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Li","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Hypertension, Beijing Anzhen Hospital of Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Juan","family":"Hu","sequence":"additional","affiliation":[{"name":"Teaching and Research Section of Community Nursing, School of Nursing, University of South China, Hengyang, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"2025121510580097000_8.5.e019719.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.184182"},{"key":"2025121510580097000_8.5.e019719.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61766-8"},{"key":"2025121510580097000_8.5.e019719.3","first-page":"557","article-title":"Hypertension Canada\u2019s 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults","volume":"33","author":"Leung","year":"2017","journal-title":"Can J Cardiol"},{"key":"2025121510580097000_8.5.e019719.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2009.08.003"},{"key":"2025121510580097000_8.5.e019719.5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016602","article-title":"Prevalence of metabolic syndrome, discrete or comorbid diabetes and hypertension in sub-Saharan Africa among people living with HIV versus HIV-negative populations: a systematic review and meta-analysis protocol","volume":"7","author":"Todowede","year":"2017","journal-title":"BMJ Open"},{"key":"2025121510580097000_8.5.e019719.6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11906-017-0759-5","article-title":"Molecular mechanisms of sodium-sensitive hypertension in the metabolic syndrome","volume":"19","author":"Nizar","year":"2017","journal-title":"Curr Hypertens Rep"},{"key":"2025121510580097000_8.5.e019719.7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3109\/10641963.2013.810226","article-title":"Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study risk factor sub-analysis","volume":"36","author":"Teramoto","year":"2014","journal-title":"Clin Exp Hypertens"},{"key":"2025121510580097000_8.5.e019719.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406656"},{"key":"2025121510580097000_8.5.e019719.9","first-page":"CD009462","article-title":"Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia","volume":"11","author":"Izquierdo-Palomares","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121510580097000_8.5.e019719.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600177"},{"key":"2025121510580097000_8.5.e019719.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600176"},{"key":"2025121510580097000_8.5.e019719.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12948-0"},{"key":"2025121510580097000_8.5.e019719.13","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464002-00005"},{"key":"2025121510580097000_8.5.e019719.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.08.033"},{"key":"2025121510580097000_8.5.e019719.15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamainternmed.2017.1442","article-title":"Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the ALLHAT-LLT randomized clinical trial","volume":"177","author":"Han","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2025121510580097000_8.5.e019719.16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/jch.12139","article-title":"Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)","volume":"15","author":"Margolis","year":"2013","journal-title":"J Clin Hypertens"},{"key":"2025121510580097000_8.5.e019719.17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cpcardiol.2017.03.001","article-title":"Clinical perspective on antihypertensive drug treatment in adults with grade 1 hypertension and low-to-moderate cardiovascular risk: an international expert consultation","volume":"42","author":"Morales Salinas","year":"2017","journal-title":"Curr Probl Cardiol"},{"key":"2025121510580097000_8.5.e019719.18","unstructured":"Review Manager (RevMan) [Computer program] Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014."},{"key":"2025121510580097000_8.5.e019719.19","unstructured":"Higgins JPT , Green S , eds. Cochrane handbook for systematic reviews of interventions version 5.1.0. (updated Mar 2011)."},{"key":"2025121510580097000_8.5.e019719.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7108.600"},{"key":"2025121510580097000_8.5.e019719.21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"J Gen Intern Med"},{"key":"2025121510580097000_8.5.e019719.22","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009904"},{"key":"2025121510580097000_8.5.e019719.23","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.108.021949"},{"key":"2025121510580097000_8.5.e019719.24","unstructured":"Sch\u00fcnemann H , Bro\u017cek J , Guyatt G , et al . GRADE handbook for grading quality of evidence and strength of recommendation. (updated Oct 2013)."},{"key":"2025121510580097000_8.5.e019719.25","unstructured":"GRADEpro Guideline Development Tool [Software] [Computer program]. GRADEpro guideline development tool software: Developed by Evidence Prime, Inc, 2015."},{"key":"2025121510580097000_8.5.e019719.26","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1517\/14656566.2010.491512","article-title":"Current role of statins in the treatment of essential hypertension","volume":"11","author":"Kostapanos","year":"2010","journal-title":"Expert Opin Pharmacother"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-019719","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T18:58:08Z","timestamp":1765825088000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-019719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,31]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/bmjopen-2017-019719"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-019719","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}